United States · 
Who invested in Biomotum?
Biomotum's investors include National Institutes of Health and Elevate Capital.
20242025
?Venture$290KSeedUnited States · Seed startup
Who invested in Biomotum
2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$290Kraised across 2 rounds since 2023, from 2 sources
- Latest round
- Seed, $290KMar 2025
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture Mar 2023
- Biggest round
- $290K Seed · Mar 2025
- Between rounds
- 2 years from the last two
The rounds
- Mar 2025
- Mar 2023
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list Biomotum as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Biomotum
How much has Biomotum raised?
Biomotum has raised $290K across 2 rounds since 2023. One round did not disclose an amount, so the total is a floor.
When did Biomotum last raise?
Biomotum's most recent round was a Seed of $290K in Mar 2025.
What was Biomotum's biggest round?
Its most recent round, $290K in Mar 2025, is also its largest on record.
Who backed Biomotum first?
Biomotum's first round on record, in Mar 2023, was backed by National Institutes of Health.
What stage is Biomotum at?
Biomotum's latest named round is a Seed, in Mar 2025.
Where is Biomotum based?
Biomotum is based in the United States.
Companies like Biomotum
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.